Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ketone doai
Patent
1990-03-02
1991-10-22
Friedman,
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ketone doai
514718, 514678, 514685, A01N 3500, A01N 3114
Patent
active
050596276
ABSTRACT:
A compound of the formula: ##STR1## wherein R.sup.1 is a lower alkyl group; R.sup.2 is a hydrogen atom or an alkyl or alkenyl group which may be substituted; R.sup.3 and R.sup.4 each independently means a lower alkyl or lower alkoxy group or, taken together, mean a butadienylene group; and X.sup.1 and X.sup.2 each means a free hydroxy group or an esterified or etherified hydroxy group, has nerve growth factor secretion inducing activity, and a mammal suffering from degenerative nervous system disorders such as senile dementia, Alzheimer's disease, etc. is treated by administering said compound to said mammal.
REFERENCES:
patent: 4393075 (1983-07-01), Terao et al.
patent: 4436753 (1984-03-01), Imada et al.
patent: 4851413 (1989-07-01), Terao et al.
patent: 4851414 (1989-07-01), Shizuo et al.
patent: 4851431 (1989-07-01), Terao et al.
Archives of Gerontology and Geriatrics, vol. 8, No. 3, 1989, pp. 191-373.
Goto Giichi
Hayashi Kyozo
Criares T. J.
Takeda Chemical Industries Ltd.
LandOfFree
Nerve growth factor secretion inducing composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nerve growth factor secretion inducing composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nerve growth factor secretion inducing composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-108880